A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy

NCT01561755 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Difficulty with enrollment

Conditions

HIV-associated Myelopathy

Interventions

DRUG: Intravenous Immunoglobulin
DRUG: Placebo

Sponsor

David M. Simpson

Collaborators

[object Object]